{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T05:17:44Z","timestamp":1732079864984,"version":"3.28.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,18]]},"DOI":"10.7759\/cureus.73961","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T06:56:14Z","timestamp":1731999374000},"source":"Crossref","is-referenced-by-count":0,"title":["Plasmablastic Lymphoma Manifesting As Pleural Thickening and Effusion: A Case Report"],"prefix":"10.7759","author":[{"given":"Mohammed","family":"Elsayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelrahman","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giedre","family":"Andrijevskiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo JJ","year":"2015","unstructured":"Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood. 2015, 125:2323-30. 10.1182\/blood-2014-10-567479","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/BLCTT.S142814","article-title":"Plasmablastic lymphoma: current perspectives","volume":"8","author":"Lopez A","year":"2018","unstructured":"Lopez A, Abrisqueta P. Plasmablastic lymphoma: current perspectives. Blood Lymphat Cancer. 2018, 8:63-70. 10.2147\/BLCTT.S142814","journal-title":"Blood Lymphat Cancer"},{"key":"ref3","article-title":"Plasmablastic lymphoma","author":"Bhatt R","year":"2024","unstructured":"Bhatt R, Naha K, Desai DS. Plasmablastic lymphoma. Bhatt R, Naha K, Desai DS (ed): StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A4748","article-title":"A case of plasmablastic lymphoma presenting as pleural effusion","volume":"205","author":"Hickey H","year":"2022","unstructured":"Hickey H, Fedyna S, Madahar P, Amengual J. A case of plasmablastic lymphoma presenting as pleural effusion . Am J Respir Crit Care Med. 2022, 205:4748. 10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A4748","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.4395","article-title":"AIDS-associated plasmablastic lymphoma presenting as a poorly differentiated esophageal tumor: a diagnostic dilemma","volume":"14","author":"Mani D","year":"2008","unstructured":"Mani D, Guinee DG Jr, Aboulafia DM. AIDS-associated plasmablastic lymphoma presenting as a poorly differentiated esophageal tumor: a diagnostic dilemma. World J Gastroenterol. 2008, 14:4395-9. 10.3748\/wjg.14.4395","journal-title":"World J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022335","article-title":"Oral plasmablastic lymphoma: a case report","volume":"99","author":"Zizzo M","year":"2020","unstructured":"Zizzo M, Zanelli M, Martiniani R, et al.. Oral plasmablastic lymphoma: a case report. Medicine (Baltimore). 2020, 99:e22335. 10.1097\/MD.0000000000022335","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006171","article-title":"Human immunodeficiency virus-negative plasmablastic lymphoma: a case report and literature review","volume":"96","author":"Lin L","year":"2017","unstructured":"Lin L, Zhang X, Dong M, et al.. Human immunodeficiency virus-negative plasmablastic lymphoma: a case report and literature review. Medicine (Baltimore). 2017, 96:e6171. 10.1097\/MD.0000000000006171","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/BLCTT.S361320","article-title":"HIV\/AIDS associated lymphoma: review","volume":"12","author":"Berhan A","year":"2022","unstructured":"Berhan A, Bayleyegn B, Getaneh Z. HIV\/AIDS associated lymphoma: review. Blood Lymphat Cancer. 2022, 12:31-45. 10.2147\/BLCTT.S361320","journal-title":"Blood Lymphat Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.516040","article-title":"Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma","volume":"51","author":"Castillo JJ","year":"2010","unstructured":"Castillo JJ, Winer ES, Stachurski D, et al.. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. 2010, 51:2047-53. 10.3109\/10428194.2010.516040","journal-title":"Leuk Lymphoma"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio J","year":"2014","unstructured":"Morscio J, Dierickx D, Nijs J, et al.. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol. 2014, 38:875-86. 10.1097\/PAS.0000000000000234","journal-title":"Am J Surg Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21250","article-title":"HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases","volume":"83","author":"Castillo J","year":"2008","unstructured":"Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008, 83:804-9. 10.1002\/ajh.21250","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22178","article-title":"Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?","volume":"107","author":"Coleman M","year":"2006","unstructured":"Coleman M, Kostakoglu L. Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?. Cancer. 2006, 107:1425-8. 10.1002\/cncr.22178","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S136988","article-title":"Lugano 2014 criteria for assessing FDG-PET\/CT in lymphoma: an operational approach for clinical trials","volume":"11","author":"Van Heertum RL","year":"2017","unstructured":"Van Heertum RL, Scarimbolo R, Wolodzko JG, et al.. Lugano 2014 criteria for assessing FDG-PET\/CT in lymphoma: an operational approach for clinical trials. Drug Des Devel Ther. 2017, 11:1719-28. 10.2147\/DDDT.S136988","journal-title":"Drug Des Devel Ther"},{"key":"ref14","unstructured":"National Comprehensive Cancer Network. B-cell lymphomas. (2020). Accessed: November 16, 2020: https:\/\/www.nccn.org\/login."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11628","article-title":"Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma","volume":"98","author":"Wang ES","year":"2003","unstructured":"Wang ES, Straus DJ, Teruya-Feldstein J, et al.. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer. 2003, 98:1196-205. 10.1002\/cncr.11628","journal-title":"Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3589","article-title":"Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology","volume":"101","author":"Little RF","year":"2003","unstructured":"Little RF, Pittaluga S, Grant N, et al.. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood. 2003, 101:4653-9. 10.1182\/blood-2002-11-3589","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/290367-plasmablastic-lymphoma-manifesting-as-pleural-thickening-and-effusion-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T06:56:17Z","timestamp":1731999377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/290367-plasmablastic-lymphoma-manifesting-as-pleural-thickening-and-effusion-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.73961","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,18]]}}}